BIOVENTUS INC - A (BVS) Stock Income Statement
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
| TTM (2025-3-29) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 567.70M | 573.28M | 512.35M | 512.10M | 430.90M | |||
| Minority Interest Expense | 9.56M | 10.29M | 24.46M | 54.70M | 9.80M | |||
| Cost Of Goods | 184.80M | 185.05M | 184.15M | 181.00M | 128.20M | |||
| Gross Profit | 382.90M | 388.23M | 328.19M | 331.10M | 302.70M | |||
| Operating Expenses | 358.66M | 363.61M | 326.89M | 386.20M | 282.50M | |||
| Research and Development | 14.05M | 13.64M | 13.45M | 25.90M | 19.00M | |||
| Selling, General, and Administrative Expenses | 335.99M | 340.89M | 303.88M | 332.60M | 254.30M | |||
| Operating Income | 24.24M | 24.62M | 1.31M | -55.00M | 20.20M | |||
| Interest Income/Expense | -33.13M | -35.96M | -38.62M | -24.70M | 1.80M | |||
| Other Income/Expense | -1.90M | -1.19M | -767.00K | 11.80M | -4.00M | |||
| Non Recurring Items | -36.68M | -36.60M | -83.03M | -196.00M | -10.30M | |||
| Income Before Taxes | -47.47M | -49.13M | -121.11M | -263.90M | 7.60M | |||
| Income Tax | -6.29M | -5.29M | 85.00K | -50.50M | -2.00M | |||
| Net Income | -31.61M | -33.54M | -156.23M | -158.70M | 19.40M | |||
| EBITDA | 73.88M | 74.17M | 58.67M | 11.80M | 55.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.49 | -0.52 | -2.49 | -2.59 | 0.43 | |||
| Non GAAP EPS | 0.48 | 0.47 | 0.00 | 0.16 | 0.82 | |||
| Statistics | ||||||||
| Gross Profit Margin | 67.45% | 67.72% | 64.06% | 64.66% | 70.25% | |||
| Profit Margin | -5.57% | -5.85% | -30.49% | -30.99% | 4.50% | |||
| Operating Profit Margin | 4.27% | 4.29% | 0.26% | -10.74% | 4.69% | |||
All data in USD